Partnership Expansion Mawdsleys has recently expanded partnerships with companies like Manx Healthcare and Cipla, presenting opportunities for sales growth by leveraging these new relationships for distribution of contract and non-contract products to hospitals.

Named Patient Supply Program The launch of the Named Patient Supply program by Mawdsleys in collaboration with Meabco A/S allows access to unlicensed medicines for conditions like metastatic breast cancer and incurable pancreatic cancer. This initiative opens avenues for sales targeting oncologists within the EU.

International Sales Expansion With a focus on international sales in the healthcare sector, Mawdsleys offers wholesale services and clinical trial supply to hospitals and academia, creating opportunities for cross-border sales growth in pharmaceutical products.

Tech-Driven Operations Utilizing a tech stack including MySQL, Google Font API, and Twitter, Mawdsleys showcases a commitment to technological advancement. Sales development representatives can leverage this to pitch tech-enabled solutions to potential clients in the healthcare and pharmaceutical industry.

Industry Positioning Being a leading partner to the pharmaceutical industry in the UK, Mawdsleys' strong presence and services like Pharma 3PL, QP Release, and Regulatory Affairs contribute to a competitive advantage. Sales professionals can highlight these capabilities to attract clients seeking reliable pharmaceutical distribution solutions.